• GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site

    7 days ago - By Xconomy

    The doors have opened at a GE Healthcare-supported open-access lab for startups at AstraZeneca's former global center for oncology research and development at Alderley Park, the largest bioscience research campus in the UK. The AstraZeneca site in Macclesfield, UK, housed 3,500 staff and was instrumental in developing a number of its cancer drugs including tamoxifen , goserelin , bicalutamide , anastrozole , and gefitinib. But in 2013, the Anglo-Swedish Big Pharma firm exited the site as part of a restructuring that moved its global R&D center and corporate headquarters to Cambridge, UK...
    Read more ...

     

  • AstraZeneca creates $1B Chinese fund, vows to double R&D team

    AstraZeneca creates $1B Chinese fund, vows to double R&D team

    7 days ago - By Fierce Biotech

    AstraZeneca is stepping up its commitment to China, detailing plans to double the head count at its Shanghai R&D site and create a $1 billion investment fund. The initiatives build on the rapid growth AstraZeneca has achieved in China in recent years.
    Read more ...